News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
Contract research organisation SynteractHCR has made Etienne Drouet VP of Strategic Development.
The CRO said it created this new position to add to its oncology and complex trial expertise as it “continues its focus on the small and mid-size biopharma segment.”
Drouet has more than 20 years of experience in executive leadership, clinical trial management, and R&D within the contract research and biopharmaceutical industries.
He will join SynteractHCR’s senior management team, reportig directly to CEO Wendel Barr.
“Since we work with smaller and mid-sized companies on complex global trials, integrating his extensive drug development knowledge is key to further improving both the strategic thinking and executional support our clients request,” said Barr.
Drouet joins SynteractHCR from Premier Research where he was Executive Director, Global Oncology. He previously held project management positions at ICON, AAI Pharma, and Cvitkovic and Associés Consultants.